Back A A A Font Size Receive E-mail Alerts Press Releases

MicroPort® Listed as "2017 China Import & Export High Quality and Credibility Enterprises"


Shanghai, China – Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") was listed as "2017 China Import & Export High Quality and Credibility Enterprises" by China Entry & Exit Inspection and Quarantine Association ("CIQA"). According to "High Quality and Credibility Enterprises Management Regulations" and "Quality and Credibility Program Implementation Schemes", there are six selection procedures including application submission, review by local entry & exit inspection and quarantine associations, approval by entry-exit inspection and quarantine bureaus, expert review, and public notification. In the end, a total of 663 companies passed all of these strict selection procedures to become "2017 China Import & Export High Quality and Credibility Enterprises".
To select "China High Quality and Credibility Enterprises" is an important measure for General Administration of Quality Supervision, Inspection and Quarantine of China to promote the construction of credibility and honor import and export enterprises with independent brand, industry leading quality, and good credibility in the international markets. Award-wining companies will be recommended as AA credit rating companies of entry-exit inspection and quarantine bureaus to enjoy a series of favored policies such as fast-track review and approval procedure and quick customs clearance.
"Quality" ranks the top of MicroPort®'s eight core values as MicroPort® employees are always enthusiastic and passionate about maintaining the highest standards of quality to make our branding ideology "The Patient Always Comes First" come true. MicroPort®‘s core value and competitiveness result from high-quality, reliable, delicate and cost-effective products and impressive customer service. MicroPort® has established a quality management system in accordance with the China Food and Drug Administration ("CFDA") regulations, and have obtained ISO 13485 certificates for the design, development, production and distribution of most of the products we currently offer. Also, the company successfully passed on-site audit of CFDA and other counterpart authorities of European Union, Japan and etc., and has received certification from third-part institutions such as DEKRA for its system and products to ensure the product quality is strictly controlled during its life span. At the same time, "Credibility" is also the foundation of MicroPort®'s corporate culture and the key to its sustainable success. MicroPort® always pays special attention to credibility construction and was awarded the honorable distinction of "Five Star Credit Enterprise" for several times.
In the future, MicroPort® will continue to carry forward the management credo of "eyes for greatness, hands on details" and strive for perfection and innovation to offer more high-quality products for patients and doctors. At the same time, as the "High Quality and Credibility Enterprise", MicroPort® will further improve its quality management and enhance the awareness of its credibility and brand, and meanwhile act as a role model to make contributions to the overall environment of China's medical device industry.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 12 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to:

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 1998-2018 MicroPort Scientific Corporation

Leanne Li
Board Secretary and Vice President of Corporate General Affairs
MicroPort Scientific Corporation
Tel: (86)(21) 38954600-6953


[Prev]:MicroPort® EP Attends 2017 Guangdong Medical Association Cardiology Academic Annual Meeting to Display Columbus™
[Next]:MicroPort® Orthopedics Attends Elite Arthroplasty Course-EAC-ISKAA in India